Publikationstyp: Konferenz: Sonstiges
Art der Begutachtung: Peer review (Abstract)
Titel: Impact of a diabetes disease management program on quality of care and costs : propensity score-matched real-world data from Switzerland
Autor/-in: Carlander, Maria
Höglinger, Marc
Trottmann, Maria
Rhomberg, Birgitta
Caviglia, Cornelia
Rohrbasser, Adrian
Frei, Christian
Eichler, Klaus
et. al: No
DOI: 10.1016/j.jval.2020.08.658
Erschienen in: Value in Health
Band(Heft): 23
Heft: 2
Seiten: S516
Angaben zur Konferenz: Virtual ISPOR Europe 2020, Online, 16-19 November 2020
Erscheinungsdatum: 2020
Verlag / Hrsg. Institution: Elsevier
ISSN: 1098-3015
Sprache: Englisch
Fachgebiet (DDC): 362: Gesundheits- und Sozialdienste
616: Innere Medizin und Krankheiten
Zusammenfassung: Objectives: Structured treatment programs have been recommended for management of patients with chronic conditions to overcome ill-coordinated care. We aimed to evaluate a disease management program (DMP) for diabetes mellitus patients in Switzerland. Methods: We performed a prospective observational study with a propensity score-matched usual care control group from a claims database. We included type-1 and type-2 diabetes patients from a primary care setting. The DMP (intervention) comprised a structured treatment approach with an individual treatment plan, treatment goals and an interprofessional team approach. Our comprehensive outcome measures included quality of life (QOL: EQ-5D-5L), pre-defined indicators for diabetes guideline adherence, number of used services and direct medical costs. We applied a difference-in-difference (DID) approach to compare DMP with usual care (follow-up 1 year). Costs were calculated with non parametric bootstrapping (2017 Swiss Francs, CHF; conversion rate to Euros: 0.85) from a third-party payer perspective (Swiss health care insurance). Results: QOL in a sub-sample of 80 patients did not change during follow-up (mean utility 0.89 at baseline and follow-up; p=0.94). Guideline adherence showed slight improvements for DMP. For example, “non-adherence” (baseline DMP: 19%) decreased in the DMP group by -3 %-points (DID; 95%-CI: -0.07 to 0.01) but not in the control group. A general trend emerged, though mostly not statistically significant, with less used services in the DMP group compared to the control group. Costs increased in both groups during follow-up, but the increase was higher in the control group (DID, mean total costs per patient per year: CHF -950.00 [95%-CI: -1959.53 to 59.56]). Such a negative difference-in-difference estimate in favor of DMP also emerged for cost sub-categories (e.g. costs for inpatient and outpatient care). Conclusions: The structured treatment program under evaluation is a promising approach to improve diabetes care in a Swiss primary care setting but more follow-up data are needed.
URI: https://digitalcollection.zhaw.ch/handle/11475/21992
Volltext Version: Publizierte Version
Lizenz (gemäss Verlagsvertrag): Lizenz gemäss Verlagsvertrag
Departement: School of Management and Law
Organisationseinheit: Winterthurer Institut für Gesundheitsökonomie (WIG)
Enthalten in den Sammlungen:Publikationen School of Management and Law

Dateien zu dieser Ressource:
Es gibt keine Dateien zu dieser Ressource.


Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.